FORT COLLINS, Colo.--(BUSINESS WIRE)--Inviragen, Inc. announced today that Dr. Dan T. Stinchcomb, Inviragen’s Chief Executive Officer, will represent the company’s business and product development strategies at worldwide global health forums this month. On May 11th, Dr. Stinchcomb participated in a panel addressing the question, “Is R & D meeting global disease challenges?” at the Health and Development Investment Forum in Abu Dhabi, United Arab Emirates. Dr. Stinchcomb was joined by representatives of non-profit initiatives and major pharmaceutical companies on the panel. “The GCC Health and Development Investment Forum brought together leaders in global health initiatives worldwide with local investors and public health experts in the United Arab Emirates and other gulf states,” commented Dr. Stinchcomb. “Our panel discussed the gaps in funding for global health research and strategies for filling those gaps.”
